Title |
Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial
|
---|---|
Published in |
Neuropsychiatric Disease and Treatment, March 2015
|
DOI | 10.2147/ndt.s78696 |
Pubmed ID | |
Authors |
Serge Brand, Vahid Farnia, Jalal Shakeri, Mehdi Shirzadifar, Mansour Rezaei, Hafez Bajoghli, Edith Holsboer-Trachsler |
Abstract |
A substantial disadvantage of psychopharmacological treatment of major depressive disorder (MDD) with selective serotonin-reuptake inhibitors (SSRIs) is the impact on sexual dysfunction. The aim of the present study was to investigate whether the oil of Rosa damascena can have a positive influence on SSRI-induced sexual dysfunction (SSRI-I SD) of male patients who are suffering from MDD and are being treated with SSRIs. In a double-blind, randomized, and placebo-controlled clinical trial, a total of 60 male patients treated with an SSRI and suffering from MDD (mean age =32 years) and SSRI-I SD were randomly assigned to take either verum (R. damascena oil) or a placebo. Patients completed self-ratings of depression and sexual function at baseline, at 4 weeks later, and at the end of the study, 8 weeks after it started. Over time, sexual dysfunction improved more in the verum group than in the control group. Improvements were observed in the verum group from week 4 to week 8. Self-rated symptoms of depression reduced over time in both groups, but did so more so in the verum group than in the control group. This double-blind, randomized, and placebo-controlled clinical trial showed that the administration of R. damascena oil ameliorates sexual dysfunction in male patients suffering from both MDD and SSRI-I SD. Further, the symptoms of depression reduced as sexual dysfunction improved. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Unknown | 68 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 12 | 17% |
Student > Ph. D. Student | 9 | 13% |
Student > Bachelor | 9 | 13% |
Researcher | 7 | 10% |
Student > Doctoral Student | 4 | 6% |
Other | 12 | 17% |
Unknown | 16 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 14 | 20% |
Psychology | 10 | 14% |
Agricultural and Biological Sciences | 9 | 13% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
Biochemistry, Genetics and Molecular Biology | 4 | 6% |
Other | 10 | 14% |
Unknown | 17 | 25% |